CTOs on the Move


 
FocusOne is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sandy Springs Fitness

Sandy Springs Fitness is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Boriken Neighborhood Health Ctr.

The Boriken - School Health Program has provided primary care services in East Harlem schools since 1983 The Program operates clinics which offer medical and mental health services in three elementary schools (Public Schools 7, 112 and 155).

Andrus

Andrus nurtures hope in children by providing care that empowers them to succeed and by promoting innovation and standards of excellence in the care of children in our community and beyond. Andrus nurtures social and emotional well-being in children and their families by delivering a broad range of vital services and by providing research, training and innovative program models that promote standards of excellence for professional performance in and beyond our service community.  

Rocky Mountain Health Plans

Rocky Mountain Health Plans is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Grand Junction, CO. To find more information about Rocky Mountain Health Plans, please visit www.rmhp.org

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III